|
2025 Journal Article Disinfectant and antibiotic resistance in Mycobacterium abscessus water isolatesPatterson-Fahy, Kirby, Carter, Robyn, Taylor, Steven L., Guo, Jianhua and Thomson, Rachel M. (2025). Disinfectant and antibiotic resistance in Mycobacterium abscessus water isolates. Microbiology Spectrum, 13 (7) e0337424, 1-12. doi: 10.1128/spectrum.03374-24 |
|
2025 Journal Article P100 Adverse events related to study drugs in finding the optimal regimen for Mycobacterium abscessus treatment (FORMaT) trialWainwright, C., Hicks, D., Rice, M., Jong, T., Gailer, N., Joshi, S., Wang, X., Burke, A., Thomson, R., Grimwood, K., Bell, S. and Clark, J. (2025). P100 Adverse events related to study drugs in finding the optimal regimen for Mycobacterium abscessus treatment (FORMaT) trial. Journal of Cystic Fibrosis, 24, S97-S98. doi: 10.1016/j.jcf.2025.03.118 |
|
2025 Journal Article P101 Prevalence of nausea and vomiting and anti-emetic use in the tinding the optimal regimen for Mycobacterium abscessus treatment (Format) trialWainwright, C., Hicks, D., Rice, M., Jong, T., Joshi, S., Wang, X., Burke, A., Thomson, R., Grimwood, K., Bell, S. and Clark, J. (2025). P101 Prevalence of nausea and vomiting and anti-emetic use in the tinding the optimal regimen for Mycobacterium abscessus treatment (Format) trial. Journal of Cystic Fibrosis, 24, S98. doi: 10.1016/j.jcf.2025.03.119 |
|
2025 Journal Article World Bronchiectasis 2025—Inclusive Lungs, Diverse SolutionsThomson, Rachel Mary and Morgan, Lucy Catriona (2025). World Bronchiectasis 2025—Inclusive Lungs, Diverse Solutions. Respirology, 30 (7), 552-554. doi: 10.1111/resp.70063 |
|
2025 Journal Article A pilot study to assess the effect of intermittent inhaled nitric oxide as treatment of nontuberculous mycobacteria lung infectionThomson, Rachel M., Burke, Andrew J., Morgan, Lucy C. and Colin, Andrew A. (2025). A pilot study to assess the effect of intermittent inhaled nitric oxide as treatment of nontuberculous mycobacteria lung infection. Annals of the American Thoracic Society, 22 (7), 1092-1097. doi: 10.1513/annalsats.202407-745rl |
|
2025 Journal Article Infection by clonally related Mycobacterium abscessus isolates: the role of drinking waterThomson, Rachel M., Wheeler, Nicole, Stockwell, Rebecca E., Bryant, Josephine, Taylor, Steven L, Leong, Lex E. X., Le, Trieu, Rogers, Geraint B, Carter, Robyn, Sherrard, Laura J, Powell, Harry, Simpson, Graham, Patterson-Fahy, Kirby, Wainwright, Claire E., Floto, R. Andres, Parkhill, Julian and Bell, Scott C. (2025). Infection by clonally related Mycobacterium abscessus isolates: the role of drinking water. American Journal of Respiratory and Critical Care Medicine, 211 (5), 842-853. doi: 10.1164/rccm.202409-1824oc |
|
2025 Journal Article Pediatric physiotherapy management of airway clearance therapy and exercise: data from the Australian Bronchiectasis RegistryWebb, Elizabeth M., Holland, Anne E., Chang, Anne B., Middleton, Peter G., Thomson, Rachel, Wong, Conroy, Jayaram, Lata, Holmes‐Liew, Chien‐Li, Morgan, Lucy and Lee, Annemarie L. (2025). Pediatric physiotherapy management of airway clearance therapy and exercise: data from the Australian Bronchiectasis Registry. Pediatric Pulmonology, 60 (1) e27370, 1-9. doi: 10.1002/ppul.27370 |
|
2024 Journal Article Current physiotherapy practice for adults with bronchiectasis: data from the Australian Bronchiectasis RegistryWebb, Elizabeth M., Holland, Anne E., Chang, Anne B., Burr, Lucy, Holmes-Liew, Chien-Li, King, Paul T., Middleton, Peter G., Morgan, Lucy, Thomson, Rachel M., Wong, Conroy and Lee, Annemarie L. (2024). Current physiotherapy practice for adults with bronchiectasis: data from the Australian Bronchiectasis Registry. Respiratory Medicine, 233 107777, 1-8. doi: 10.1016/j.rmed.2024.107777 |
|
2024 Journal Article Inhaled colistimethate sodium in patients with bronchiectasis and Pseudomonas aeruginosa infection: results of PROMIS-I and PROMIS-II, two randomised, double-blind, placebo-controlled phase 3 trials assessing safety and efficacy over 12 monthsHaworth, Charles S., Shteinberg, Michal, Winthrop, Kevin, Barker, Alan, Blasi, Francesco, Dimakou, Katerina, Morgan, Lucy C., O'Donnell, Anne E., Ringshausen, Felix C., Sibila, Oriol, Thomson, Rachel M., Carroll, Kevin J., Pontenani, Federica, Castellani, Paola, Chalmers, James and PROMIS Trial Investigators, (2024). Inhaled colistimethate sodium in patients with bronchiectasis and Pseudomonas aeruginosa infection: results of PROMIS-I and PROMIS-II, two randomised, double-blind, placebo-controlled phase 3 trials assessing safety and efficacy over 12 months. Lancet Respiratory Medicine, 12 (10), 787-798. doi: 10.1016/-2600(24)00225-X |
|
2024 Journal Article Inhaled colistimethate sodium in patients with bronchiectasis and Pseudomonas aeruginosa infection: results of PROMIS-I and PROMIS-II, two randomised, double-blind, placebo-controlled phase 3 trials assessing safety and efficacy over 12 monthsHaworth, Charles S, Shteinberg, Michal, Winthrop, Kevin, Barker, Alan, Blasi, Francesco, Dimakou, Katerina, Morgan, Lucy C, O'Donnell, Anne E, Ringshausen, Felix C, Sibila, Oriol, Thomson, Rachel M, Carroll, Kevin J, Pontenani, Federica, Castellani, Paola and Chalmers, James D (2024). Inhaled colistimethate sodium in patients with bronchiectasis and Pseudomonas aeruginosa infection: results of PROMIS-I and PROMIS-II, two randomised, double-blind, placebo-controlled phase 3 trials assessing safety and efficacy over 12 months. The Lancet Respiratory Medicine, 12 (10), 787-798. doi: 10.1016/s2213-2600(24)00225-x |
|
2024 Journal Article OPTIMA: an open-label, non-comparative pilot trial of inhaled molgramostim in pulmonary nontuberculous mycobacterial infectionThomson, Rachel M., Loebinger, Michael R., Burke, Andrew J., Morgan, Lucy C., Waterer, Grant W. and Ganslandt, Cecilia (2024). OPTIMA: an open-label, non-comparative pilot trial of inhaled molgramostim in pulmonary nontuberculous mycobacterial infection. Annals of the American Thoracic Society, 21 (4), 568-576. doi: 10.1513/annalsats.202306-532oc |
|
2023 Journal Article Extended water stagnation in buildings during the COVID-19 pandemic increases the risks posed by opportunistic pathogensHuang, Casey K., Weerasekara, Anjani, Lu, Ji, Carter, Robyn, Weynberg, Karen D., Thomson, Rachel, Bell, Scott and Guo, Jianhua (2023). Extended water stagnation in buildings during the COVID-19 pandemic increases the risks posed by opportunistic pathogens. Water Research: X, 21 100201, 100201. doi: 10.1016/j.wroa.2023.100201 |
|
2023 Journal Article Things They Are a Changing in the Field of Nontuberculous MycobacteriaKasperbauer, Shannon and Thomson, Rachel (2023). Things They Are a Changing in the Field of Nontuberculous Mycobacteria. Clinics in Chest Medicine, 44 (4), xiii-xiv. doi: 10.1016/j.ccm.2023.09.001 |
|
2023 Journal Article In vitro susceptibility testing of imipenem- relebactam and tedizolid against 102 Mycobacterium abscessus isolatesBurke, Andrew, Carter, Robyn, Tolson, Carla, Congdon, Jacob, Duplancic, Christine, Bursle, Evan, Bell, Scott C., Roberts, Jason A. and Thomson, Rachel (2023). In vitro susceptibility testing of imipenem- relebactam and tedizolid against 102 Mycobacterium abscessus isolates. International Journal of Antimicrobial Agents, 62 (4) 106938, 1-6. doi: 10.1016/j.ijantimicag.2023.106938 |
|
2023 Journal Article A systematic review of the clinical impact of small colony variants in patients with cystic fibrosisRyan, Harrigan, Ballard, Emma, Stockwell, Rebecca E., Duplancic, Christine, Thomson, Rachel M., Smith, Kimberley and Bell, Scott C. (2023). A systematic review of the clinical impact of small colony variants in patients with cystic fibrosis. BMC Pulmonary Medicine, 23 (1) 323, 1-10. doi: 10.1186/s12890-023-02611-4 |
|
2023 Journal Article Environmental risk of nontuberculous mycobacterial infection: strategies for advancing methodologyMercaldo, Rachel A., Marshall, Julia E., Cangelosi, Gerard A., Donohue, Maura, Falkinham, Joseph O., Fierer, Noah, French, Joshua P., Gebert, Matthew J., Honda, Jennifer R., Lipner, Ettie M., Marras, Theodore K., Morimoto, Kozo, Salfinger, Max, Stout, Janet, Thomson, Rachel and Prevots, D. Rebecca (2023). Environmental risk of nontuberculous mycobacterial infection: strategies for advancing methodology. Tuberculosis, 139 102305, 102305. doi: 10.1016/j.tube.2023.102305 |
|
2023 Journal Article Nontuberculous Mycobacteria in Cystic Fibrosis in the Era of Cystic Fibrosis Transmembrane Regulator ModulatorsBurke, Andrew, Thomson, Rachel M., Wainwright, Claire E. and Bell, Scott C. (2023). Nontuberculous Mycobacteria in Cystic Fibrosis in the Era of Cystic Fibrosis Transmembrane Regulator Modulators. Seminars in Respiratory and Critical Care Medicine, 44 (02), 287-296. doi: 10.1055/s-0042-1759883 |
|
2023 Journal Article ‘Teach me how to look after myself’: what people with bronchiectasis want from education in a pulmonary rehabilitation settingLee, Annemarie L., Smith, Rebecca, Burr, Lucy, Chang, Anne B., Holmes‐Liew, Chien‐Li, King, Paul, Middleton, Peter, Morgan, Lucy, Smith, Daniel, Thomson, Rachel, Waterer, Grant, Wong, Conroy and McAleer, Rachael (2023). ‘Teach me how to look after myself’: what people with bronchiectasis want from education in a pulmonary rehabilitation setting. The Clinical Respiratory Journal, 17 (1), 59-69. doi: 10.1111/crj.13563 |
|
2022 Journal Article Characterizing and correcting immune dysfunction in non-tuberculous mycobacterial diseaseRatnatunga, Champa N., Tungatt, Katie, Proietti, Carla, Halstrom, Sam, Holt, Michael R., Lutzky, Viviana P., Price, Patricia, Doolan, Denise L., Bell, Scott C., Field, Matt A., Kupz, Andreas, Thomson, Rachel M. and Miles, John J. (2022). Characterizing and correcting immune dysfunction in non-tuberculous mycobacterial disease. Frontiers in Immunology, 13 1047781, 1-20. doi: 10.3389/fimmu.2022.1047781 |
|
2022 Journal Article Quantifying the effectiveness of ultraviolet-C (UV-C) light at inactivating airborne Mycobacterium abscessusNguyen, Thi Tham, He, Congrong, Carter, Robyn, Ballard, Emma L., Smith, Kim, Groth, Robert, Jaatinen, Esa, Kidd, Timothy J., Thomson, Rachel, Tay, George, Johnson, Graham R., Bell, Scott C. and Knibbs, Luke D. (2022). Quantifying the effectiveness of ultraviolet-C (UV-C) light at inactivating airborne Mycobacterium abscessus. Journal of Hospital Infection, 132, 133-139. doi: 10.1016/j.jhin.2022.10.008 |
